Type I interferon limits central nervous system autoimmunity by modulating the microRNA-21–FOXO1 axis in pathogenic T helper 17 cells

Journal:

Science Translational Medicine

Published:

2025-09-10

DOI:

10.1126/scitranslmed.adp5802

Affiliations:

5

Authors:

20

Go to article

Institutions	Authors	Share
Brigham and Women's Hospital (BWH), United States of America (USA)	18.500000 18.500000	0.93
Boston University (BU), United States of America (USA)	0.500000	0.03
Massachusetts General Hospital (MGH), United States of America (USA)	0.500000	0.03
The Ottawa Hospital (TOH), Canada	0.500000	0.03

Interested in Neurosciences?